TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prostaglandin Insert (Propess) Versus Trans-cervical Balloon Catheter for Out-patient Labour Induction: A Randomised Controlled Trial of Feasibility
Brief Summary: This study will randomise low-risk women to compare the effectiveness of trans-cervical balloon catheter for pre-induction cervical ripening for out-patient induction of labour with current practice (Propess). Women will be randomised to two treatment groups. The investigators wish to explore if such a trial is feasible, acceptable to women and what data collection is required for a future trial. Since no data exist, the investigators propose a study with approximately 60 women in each arm across two recruiting sites.


Options:
A: Arm Label: misoprostol group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol | Arm Label: misoprostol and foley bulb group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol, Device: Foley bulb | Intervention Type: DEVICE; Name: misoprostol; Assigned to Arm(s): misoprostol and foley bulb group, misoprostol group | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): misoprostol and foley bulb group
B: Arm Label: Cook Cervical balloon; Type: ACTIVE_COMPARATOR; Interventions: Device: Cook cervical balloon | Arm Label: Prostin E2 Vaginal suppository; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prostin E2 Vaginal Suppository | Intervention Type: DEVICE; Name: Cook cervical balloon; Assigned to Arm(s): Cook Cervical balloon | Intervention Type: DRUG; Name: Prostin E2 Vaginal Suppository; Assigned to Arm(s): Prostin E2 Vaginal suppository
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Induction of labor with foley balloon - 60cc of saline | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Induction of labor with foley balloon with 30cc | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon - 60cc of saline; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon with 30cc; Assigned to Arm(s): 2
D: Intervention Type: DRUG; Name: low dose oxytocin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Study of the Management of the Patient's Disease Based on the Life Log Data of Patients With Lifestyle-related Diseases Through a Wearable Device
Brief Summary: In order to study the effectiveness of personalized healthcare intervention for lifestyle-related diseases, investigators designed this study using mobile application and clinical feedback from clinicians


Options:
A: Intervention Type: OTHER; Name: educational intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: internet-based intervention; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: evaluation of cancer risk factors; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fecal occult blood test; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: screening colonoscopy; Assigned to Arm(s): N/A
B: Arm Label: Standard tablet computer; Type: EXPERIMENTAL; Interventions: Other: Standard tablet computer | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Enhanced tablet computer; Type: EXPERIMENTAL; Interventions: Other: Enhanced tablet computer | Intervention Type: OTHER; Name: Standard tablet computer; Assigned to Arm(s): Standard tablet computer | Intervention Type: OTHER; Name: Enhanced tablet computer; Assigned to Arm(s): Enhanced tablet computer
C: Arm Label: Online disease management; Type: EXPERIMENTAL; Interventions: Behavioral: Online disease management | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Online disease management; Assigned to Arm(s): Online disease management
D: Arm Label: Mobile application user group; Type: EXPERIMENTAL; Interventions: Behavioral: Daily health-related lifestyle modification prescription | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Daily health-related lifestyle modification prescription; Assigned to Arm(s): Mobile application user group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase IIIb/IV Cohort Event Monitoring Study To Evaluate, In Real Life Setting, The Safety And Tolerability In Malaria Patients Of The Fixed-Dose Artemisinin-Based Combination Therapy Pyramax®
Brief Summary: The study is to be performed in public health facilities in Central and West Africa where Pyramax will be used as treatment of uncomplicated malaria episodes, including repeat episodes. The study is to assess the safety of Pyramax, particularly in patients with underlying liver function abnormalities, in patients who have co-morbid conditions, such as HIV, and also in very small children (\<1 year of age).


Options:
A: Arm Label: Pyronaridine-artesunate; Type: EXPERIMENTAL; Interventions: Drug: Pyronaridine-artesunate | Arm Label: Artemether-lumefantrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Artemether-lumefantrine combination | Intervention Type: DRUG; Name: Pyronaridine-artesunate; Assigned to Arm(s): Pyronaridine-artesunate | Intervention Type: DRUG; Name: Artemether-lumefantrine combination; Assigned to Arm(s): Artemether-lumefantrine
B: Arm Label: pyronaridine/artesunate (6:2 mg/kg); Type: EXPERIMENTAL; Interventions: Drug: pyronaridine/artesunate | Arm Label: pyronaridine/artesunate (9:3 mg/kg); Type: EXPERIMENTAL; Interventions: Drug: pyronaridine/artesunate | Arm Label: pyronaridine/artesunate (12:4 mg/kg); Type: EXPERIMENTAL; Interventions: Drug: pyronaridine/artesunate | Intervention Type: DRUG; Name: pyronaridine/artesunate; Assigned to Arm(s): pyronaridine/artesunate (12:4 mg/kg), pyronaridine/artesunate (6:2 mg/kg), pyronaridine/artesunate (9:3 mg/kg)
C: Arm Label: arm 1; Type: EXPERIMENTAL; Interventions: Drug: Artesunate | Arm Label: arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Artesunate + Mefloquine | Intervention Type: DRUG; Name: Artesunate; Assigned to Arm(s): arm 1 | Intervention Type: DRUG; Name: Artesunate + Mefloquine; Assigned to Arm(s): arm 2
D: Arm Label: Pyramax; Type: EXPERIMENTAL; Interventions: Drug: pyronaridine artesunate | Intervention Type: DRUG; Name: pyronaridine artesunate; Assigned to Arm(s): Pyramax

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: iCanCope With Sickle Cell Disease: A Mobile Pain Management Intervention for Adolescents
Brief Summary: The project will test a tailored web and smartphone-based application (iCanCope with SCD) to improve pain self-management and functioning in youth (aged 12-18) with sickle cell disease. The program will include goal setting, peer-based social support, and pain self-management training. The investigators will determine initial program effectiveness through a pilot three-site randomized controlled trial in 160 youth randomized to treatment compared to attention control.


Options:
A: Arm Label: Education Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Arm Label: Pain Self-Management Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Pain self-management, Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Pain self-management; Assigned to Arm(s): Pain Self-Management Intervention | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education Control, Pain Self-Management Intervention
B: Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Qigong exercise; Assigned to Arm(s): N/A
C: Arm Label: Internet-based JIA Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Taking Charge | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Management | Intervention Type: BEHAVIORAL; Name: Teens Taking Charge; Assigned to Arm(s): Internet-based JIA Self-Management Program | Intervention Type: BEHAVIORAL; Name: Self-Management; Assigned to Arm(s): Attention Control Group
D: Arm Label: Treatment with manipulation; Type: EXPERIMENTAL; Interventions: Procedure: Advice and exercise-based treatment plus joint manipulation | Arm Label: Treatment without manipulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Advice and exercise-based treatment | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment plus joint manipulation; Assigned to Arm(s): Treatment with manipulation | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment; Assigned to Arm(s): Treatment without manipulation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Pilot Study.
Brief Summary: The aim of the study is to collect preliminary information on the effect of low doses of trazodone on pain intensity in patients with painful diabetic neuropathy and to evaluate the neuropathic pain symptoms, anxiety, sleep, quality of life, safety and tolerability.


Options:
A: Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Milnacipran | Arm Label: Milnacipran; Type: ACTIVE_COMPARATOR; Interventions: Drug: Milnacipran | Intervention Type: DRUG; Name: Milnacipran; Assigned to Arm(s): Milnacipran, Sugar pill
B: Intervention Type: DRUG; Name: duloxetine HCL; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A
C: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Drug: Trazodone 20 mg | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Drug: Trazodone 10 mg | Arm Label: Group 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Trazodone 20 mg; Assigned to Arm(s): Group 1 | Intervention Type: DRUG; Name: Trazodone 10 mg; Assigned to Arm(s): Group 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 3
D: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial
Brief Summary: The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Options:
A: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional inpatient hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Traditional inpatient hospitalization; Assigned to Arm(s): Inpatient hospitalization
B: Arm Label: Home initiation; Type: EXPERIMENTAL; Interventions: Device: Transcutaneous measurements of PCO2, Device: Telemonitoring, Device: EMG, Other: Home initiation of NIV | Arm Label: Inhospital initiation; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcutaneous measurements of PCO2, Device: EMG, Other: Inhospital initiation of NIV | Intervention Type: DEVICE; Name: Transcutaneous measurements of PCO2; Assigned to Arm(s): Home initiation, Inhospital initiation | Intervention Type: DEVICE; Name: Telemonitoring; Assigned to Arm(s): Home initiation | Intervention Type: DEVICE; Name: EMG; Assigned to Arm(s): Home initiation, Inhospital initiation | Intervention Type: OTHER; Name: Home initiation of NIV; Assigned to Arm(s): Home initiation | Intervention Type: OTHER; Name: Inhospital initiation of NIV; Assigned to Arm(s): Inhospital initiation
C: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Inpatient Hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Inpatient Hospitalization; Assigned to Arm(s): Inpatient hospitalization
D: Arm Label: TCM integrated group; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, massage and basic TCM treatment | Arm Label: Western Medicine group; Type: ACTIVE_COMPARATOR; Interventions: Other: rehabilitation and WM basic treatment | Intervention Type: OTHER; Name: acupuncture, massage and basic TCM treatment; Assigned to Arm(s): TCM integrated group | Intervention Type: OTHER; Name: rehabilitation and WM basic treatment; Assigned to Arm(s): Western Medicine group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial
Brief Summary: The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Options:
A: Arm Label: fluticasone furoate/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone furoate/vilanterol | Arm Label: fluticasone furoate; Type: EXPERIMENTAL; Interventions: Drug: fluticasone furoate | Arm Label: vilanterol; Type: EXPERIMENTAL; Interventions: Drug: vilanterol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: fluticasone furoate/vilanterol; Assigned to Arm(s): fluticasone furoate/vilanterol | Intervention Type: DRUG; Name: fluticasone furoate; Assigned to Arm(s): fluticasone furoate | Intervention Type: DRUG; Name: vilanterol; Assigned to Arm(s): vilanterol | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): placebo
B: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional inpatient hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Traditional inpatient hospitalization; Assigned to Arm(s): Inpatient hospitalization
C: Arm Label: CHF patients, IVR-Enhanced Care; Type: EXPERIMENTAL; Interventions: Behavioral: IVR-Enhanced Care | Arm Label: COPD patients, IVR-Enhanced Care; Type: EXPERIMENTAL; Interventions: Behavioral: IVR-Enhanced Care | Arm Label: CHF patients, Usual Discharge Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: COPD patients, Usual Discharge Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: IVR-Enhanced Care; Assigned to Arm(s): CHF patients, IVR-Enhanced Care, COPD patients, IVR-Enhanced Care
D: Intervention Type: BEHAVIORAL; Name: Self-management of chronic illness; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial
Brief Summary: The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Options:
A: Arm Label: Disease management program; Type: EXPERIMENTAL; Interventions: Other: Disease Management | Arm Label: Usual site management; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual site management | Intervention Type: OTHER; Name: Disease Management; Assigned to Arm(s): Disease management program | Intervention Type: OTHER; Name: Usual site management; Assigned to Arm(s): Usual site management
B: Arm Label: COPD, Telehealth; Type: EXPERIMENTAL; Interventions: Device: Telehealth | Arm Label: COPD, Normal clinical practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telehealth; Assigned to Arm(s): COPD, Telehealth
C: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Device: telemedicine program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: telemedicine program; Assigned to Arm(s): Telemedicine
D: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional inpatient hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Traditional inpatient hospitalization; Assigned to Arm(s): Inpatient hospitalization

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial
Brief Summary: The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Options:
A: Arm Label: Experimental_INTERCARE intervention; Type: EXPERIMENTAL; Interventions: Other: Implementation of a nurse-led model of care | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation of a nurse-led model of care; Assigned to Arm(s): Experimental_INTERCARE intervention
B: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional inpatient hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Traditional inpatient hospitalization; Assigned to Arm(s): Inpatient hospitalization
C: Arm Label: Advanced Care at Home (ACH); Type: EXPERIMENTAL; Interventions: Other: Advanced Care at Home (ACH) | Arm Label: Traditional Inpatient (Brick-and-Mortar) Hospital Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional Brick-and-Mortar Hospitalization | Intervention Type: OTHER; Name: Advanced Care at Home (ACH); Assigned to Arm(s): Advanced Care at Home (ACH) | Intervention Type: OTHER; Name: Traditional Brick-and-Mortar Hospitalization; Assigned to Arm(s): Traditional Inpatient (Brick-and-Mortar) Hospital Care
D: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Other: Very early supported discharge (VESD) | Arm Label: Control; Type: OTHER; Interventions: Other: Ordinary rehabilitation | Intervention Type: OTHER; Name: Very early supported discharge (VESD); Assigned to Arm(s): Active | Intervention Type: OTHER; Name: Ordinary rehabilitation; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Wise App Trial for Improving Health Outcomes in People Living With HIV
Brief Summary: The overall goal of this study is to design a user-centered design app linked to a smart pill box for people living with HIV (PLWH) and evaluate its effects in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a strong theoretical framework building on earlier user-centered design work and integrating a real-time monitoring device, this work has the potential to improve ART adherence in PLWH and have a sustainable public health impact.


Options:
A: Arm Label: Multicomponent mHealth Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Multicomponent mHealth Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Multicomponent mHealth Intervention; Assigned to Arm(s): Multicomponent mHealth Intervention
B: Arm Label: Smartphone-enabled app for linkage to care; Type: EXPERIMENTAL; Interventions: Other: Smartphone application, Device: Smartphone | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smartphone application; Assigned to Arm(s): Smartphone-enabled app for linkage to care | Intervention Type: DEVICE; Name: Smartphone; Assigned to Arm(s): Smartphone-enabled app for linkage to care
C: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Behavioral: Wise app with fitness reminders | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Wise app with medication adherence reminders | Intervention Type: BEHAVIORAL; Name: Wise app with medication adherence reminders; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Wise app with fitness reminders; Assigned to Arm(s): Control
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: miPlan intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: miPlan intervention; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Wise App Trial for Improving Health Outcomes in People Living With HIV
Brief Summary: The overall goal of this study is to design a user-centered design app linked to a smart pill box for people living with HIV (PLWH) and evaluate its effects in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a strong theoretical framework building on earlier user-centered design work and integrating a real-time monitoring device, this work has the potential to improve ART adherence in PLWH and have a sustainable public health impact.


Options:
A: Arm Label: Smartphone-enabled app for linkage to care; Type: EXPERIMENTAL; Interventions: Other: Smartphone application, Device: Smartphone | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smartphone application; Assigned to Arm(s): Smartphone-enabled app for linkage to care | Intervention Type: DEVICE; Name: Smartphone; Assigned to Arm(s): Smartphone-enabled app for linkage to care
B: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Behavioral: Wise app with fitness reminders | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Wise app with medication adherence reminders | Intervention Type: BEHAVIORAL; Name: Wise app with medication adherence reminders; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Wise app with fitness reminders; Assigned to Arm(s): Control
C: Arm Label: Two-way SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Two-way SMS | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Two-way SMS; Assigned to Arm(s): Two-way SMS
D: Intervention Type: BEHAVIORAL; Name: Pulse; Assigned to Arm(s): N/A

Answer: B